Nevertheless, these findings serve to reinforce the likely health benefits of a diet rich in UFAs rather than SFAs and suggest that therapeutic targeting of TNFα action and p38 MAPK activity remain potential approaches for the treatment of T2D. The gene discussed is TNF; the disease is type 2 diabetes mellitus.